SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Creative Media & Community Trust Corp. is a real estate investment trust that seeks to own, operate, and develop premier multifamily and creative office assets in vibrant and emerging communities throughout the United States. It operates through the following segments: Office, Hotel, and Lending. The Office segment consists of the rental of office space and other tenant services, including tenant reimbursements, parking, and storage space rental. The Hotel segment involves the operation of hotel properties. The Lending segment focuses on loans to small businesses. The company was founded in 1993 and is headquartered in Dallas, TX.

Creative Media & Community Trust

CMCT is trending due to news of a lending division sale, sparking interest in its micro float and potential for a short squeeze. While some traders express optimism for gains, others cite concerns over the company's debt, leading to discussions about risk management.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending following a strong earnings report and increased full-year guidance, with community members highlighting the potential for significant revenue growth and a rebrand to CorMedix Therapeutics. The community is actively discussing the impact of these results, and a conference call is scheduled where further details may be revealed. Broader discussions include the company's strategic investments and potential for shareholder value.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle ($CRCL) is trending as the stock reacts to strong earnings and a growing USDC circulation, with some community members discussing the potential for Cathie Wood to increase her position. Despite positive financial results, the stock initially experienced a dip, leading to debates about market irrationality and future price movement with the lockup period expiring soon.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

News of Luckin Coffee's potential U.S. relisting is generating buzz, with community members speculating about the timeline and impact on the stock. Discussions also involve the company's expansion plans and potential competition with Starbucks. Despite some skepticism, many longs are optimistic about Luckin's growth and future prospects.

Jumia Technologies AG engages in the provision of logistic services. It operates a pan-African e-commerce platform. It operates through the following geographical segments: West Africa, North Africa, East and South Africa, Europe, United Arab Emirates, and Others. The company was founded by Jeremy Hodara, Sacha Poignonnec, Peter Allerstorfer, Manuel Koser, Tunde Kehinde, and Raphael Afaedor in 2012 and is headquartered in Berlin, Germany.

Jumia Technologies Ag - ADR

JMIA is trending following recent earnings, with community members noting a widened loss but increased revenue. Discussions are centered on whether to buy the dip, with some expressing concerns about liquidity while others highlight positive growth and long-term profitability targets. Upcoming investor day is also a key point of focus for potential catalysts.

Leifras Co., Ltd. Engages in sport training, event and alliance & club activity support and healthcare activities. It provides services related to the organization and operations of sports schools and sports events for children and it also operate a robust social business sector, dispatching sports coaches to meet various community needs. The company was founded by Kiyotaka Ito on August 28, 2001 and is headquartered in Tokyo, Japan.

Leifras Co Ltd - ADR

LEIFRAS Co., Ltd. American Depositary Shares

$LFS is trending due to a massive surge, with community members pointing to a potential short squeeze and comparing it to other high-flying stocks. Discussions revolve around whether this run can continue and which stock could be the 'next LFS'. Some traders attribute the move to news regarding a contract in Nagoya, while others suspect a pump and dump.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

On Holding (ONON) is trending due to positive investor sentiment following raised FY25 revenue growth outlook. The community is buzzing about the company's strong sales and potential for a short squeeze, while some debate its valuation and competition within the shoe market. The focus remains on the company's growth in Asia and overall execution.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as investors debate the stock's future following recent news and ahead of an upcoming earnings report, with some expressing concerns about cash burn and others highlighting potential catalysts like FAA certification progress and partnerships. Discussions include contrasting opinions on the company's prospects versus competitors and the impact of analyst ratings, while technical analysis and potential support/resistance levels are also being closely monitored. The community is focused on both short-term trading opportunities and the long-term vision for the eVTOL sector.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

Traders are closely watching AVXL as it approaches its EMA oral explanation, the last step before a decision on its Alzheimer's drug, blarcamesine. Community chatter revolves around the potential for conditional approval and how management addresses outstanding questions, especially concerning the drug's efficacy. Recent price action suggests heightened uncertainty, with some interpreting the need for an oral explanation as a sign of regulatory scrutiny, while others remain optimistic about blarcamesine's potential benefits and market position.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending following its analyst day, where long-term growth targets were revealed, sparking optimism; the data center market is projected to reach $1 trillion by 2030. Community members are actively discussing price targets and the potential for AMD to gain market share in the AI space, with some drawing comparisons to NVDA's trajectory and others expressing skepticism.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$LCTX $SANA SANA: No fully proven large-scale production to date. While the Bothell facility opened in 2024 and supported early-stage process development, there are no public reports of completed cGMP runs for clinical doses or commercial validation. The 2025 pivot to CDMOs implies internal capabilities remain unproven at scale, with reliance on partners for any near-term output.

LCTX: Proven cGMP production capabilities. In May 2025, LCTX announced successful completion of a full production run for two distinct product candidates (OpRegen for retinal disease and VAC-NC1 for neuronal support) using its cGMP cell banking system, yielding viable cells for clinical use. This was followed by initiating a Type 1 diabetes transplant program in Sep 2025, directly deploying these capabilities to produce islet-like cells at scale (addressing ~10^9 cells per patient). Q3 2025 earnings highlighted leveraging this for overcoming industry-scale challenges, confirming operational maturity.

Jerry

$LCTX Still waiting for someone to logically disprove my claim that LCTX does not have an advantage over others for producing islet cells. So far, I&#39;ve gotten some insults (to be expected). I corrected a link. And some people seem to actually be taking me seriously. I am ultra long $SANA, don&#39;t care about LCTX at all and I think LCTX has 0 impact on Sana stock price. Not short or long LCTX. Worried for LCTX shareholders though. LCTX CEO is clearly making false claims and being secretive about their scale up process (which in the CEO&#39;s own words is WORSE than competitors). LCTX is giving me Theranos vibes.

StockTwits Web

Lineage Cell Therapeutics Inc

Sana Biotechnology Inc

LunarPixel87

$LCTX $SANA Where are you getting the 10^9 billion claim from LCTX? Sept 8 press release clearly stated hundreds of millions cells. And again, we have no public details of LCTX&#39;s process. Who is the CDMO that Sana is using? Clearly not LCTX and whatever CDMO Sana chose must be suitable to scale Sana&#39;s islet for clinical trials or they wouldn&#39;t be working with them. This implies there exists other companies just as suitable, if not more suitable, as LCTX to scale cell manufacturing. 
 
 If LCTX&#39;s process is so uniquely superior to other CDMOs, why is Sana not already partnering with them? If LCTX doesn&#39;t want to be a CDMO (this seems to be the case) and wants to make their own islet cell therapy, how are they going to get around all the IP needed to realize that that others own?

StockTwits For Android 

 SANA: No fully proven large-scale production to date. While the Bothell facility opened in 2024 and supported early-stage process development, there are no public reports of completed cGMP runs for clinical doses or commercial validation. The 2025 pivot to CDMOs implies internal capabilities remain unproven at scale, with reliance on partners for any near-term output.

LCTX: Proven cGMP production capabilities. In May 2025, LCTX announced successful completion of a full production run for two distinct product candidates (OpRegen for retinal disease and VAC-NC1 for neuronal support) using its cGMP cell banking system, yielding viable cells for clinical use. This was followed by initiating a Type 1 diabetes transplant program in Sep 2025, directly deploying these capabilities to produce islet-like cells at scale (addressing ~10^9 cells per patient). Q3 2025 earnings highlighted leveraging this for overcoming industry-scale challenges, confirming operational maturity.

Brat

@LunarPixel87 Overall, LCTX demonstrates tangible proof-of-concept in GMP manufacturing, while SANA&#39;s remain largely aspirational and now externally dependent.

 Overall, LCTX demonstrates tangible proof-of-concept in GMP manufacturing, while SANA's remain largely aspirational and now externally dependent.

@DiligentInvesting appreciate attempting a logical response. The way this is written sounds exactly like chatgpt ai style output though

 appreciate attempting a logical response. The way this is written sounds exactly like chatgpt ai style output though